Metabolomics Technology Market to Reach $10,364.1 Million in 2035, Growing at 8.3% CAGR

Metabolomics technology market valued at $4,724.2 million in 2025 and is projected to reach $10,364.1 million by 2035, growing at a CAGR of 8.3% during the forecast period (2026-2035). The market encompasses advanced analytical technologies and computational tools used to identify, quantify, and analyze metabolites in biological systems, supporting a wide range of biomedical and life science applications. The market is witnessing strong global growth driven by increasing adoption of precision medicine, rising investment in pharmaceutical and biotechnology research, and the growing importance of systems biology in understanding disease mechanisms. Expansion is further supported by technological advancements in mass spectrometry, nuclear magnetic resonance (NMR), and chromatography techniques, enabling high-throughput and high-resolution metabolite profiling. Pharmaceutical companies are increasingly integrating metabolomics into drug discovery pipelines for target identification, biomarker validation, and toxicity assessment. Additionally, the growing use of bioinformatics tools for complex data interpretation and integration is accelerating market development.

Browse the full report description of “Metabolomics Technology Market Size, Share & Trends Analysis Report by Products and Services (Metabolomics Instruments and Metabolomics Bioinformatics), by Application (Drug Discovery, Biomarkers, Toxicology, and Personalized Medicine) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/metabolomics-technology-market

According to global health and research organizations, the rapid growth of omics-based research, increasing prevalence of chronic diseases, and expanding clinical research activities are significantly strengthening the demand for metabolomics technologies. Large-scale biological databases, integrated multi-omics platforms, and advancements in computational analytics are playing a critical role in enabling data-driven decision-making and improving research outcomes across the life sciences sector.

Key Statistics: Metabolomics Technology at a Glance

• More than 70% of pharmaceutical and biotechnology companies are incorporating metabolomics into drug discovery and biomarker research workflows.
• Global R&D spending in life sciences exceeds $200 billion annually, supporting the expansion of metabolomics-based research applications.
• The number of identified human metabolites has surpassed 250,000, highlighting the growing complexity and scale of metabolomics datasets driving demand for advanced analytical technologies.

Key Innovators Driving Metabolomics Technology Transformation

The key players in the metabolomics technology market include Agilent Technologies, Inc., Bruker Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Waters Corporation., among others.

• In July 2025, Thermo Fisher Scientific introduced an advanced high-resolution mass spectrometry platform designed to enhance metabolite identification and quantification accuracy in complex biological samples, supporting next-generation metabolomics research.
• In May 2025, Agilent Technologies launched an upgraded metabolomics workflow solution integrating chromatography systems with AI-powered data analysis software to improve throughput and streamline laboratory operations.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Products and Services
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Agilent Technologies, Inc., Bruker Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Waters Corporation among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Metabolomics Technology Market Report Segment

By Products and Services

• Metabolomics Instruments
• Metabolomics Bioinformatics

By Application

• Drug Discovery
• Biomarkers
• Toxicology
• Personalized Medicine

Global Metabolomics Technology Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/metabolomics-technology-market